Jamie Graham focuses her practice on intellectual property issues involving biological and chemical technologies. Ms. Graham conducts domestic and foreign biological and chemical patent prosecution, particularly in the areas of biotechnology, diagnostics, isolation and purification methodology, immunology and pharmaceuticals. She renders patentability, patent validity and freedom-to-operate opinions; performs intellectual property due diligence; and provides advice to clients regarding various aspects of intellectual property, including inventorship determinations, licensing, transactions, pre-litigation and litigation strategies. Ms. Graham has provided intellectual property advice and services to universities, large corporations, small start-up companies and government entities and has been awarded federal and state contracts for patent legal services.
Ms. Graham has been a registered U.S. Patent Attorney since 1986. Prior to joining the firm, she served as in-house patent counsel for a pharmaceutical company. She has conducted enzyme isolation and characterization research at Sloan-Kettering Institute for Cancer Research and cardiac and allergy drug dispositon/metabolism research at Boehringer Ingelheim Ltd. Ms. Graham also performed graduate research in neuroimmunology and virology (HIV research conducted at the Centers for Disease Control and Prevention). She has been an adjunct professor of Intellectual Property Law at Emory University.
Ms. Graham was listed in The Best Lawyers of America® for Biotechnology and Life Sciences Law and Patent Law in 2019 and each of the 20 years immediately preceding. She was also named a 2012 and 2013 "Atlanta Lawyer of the Year" in the area of Biotechnology Law by The Best Lawyers in America®. Ms. Graham was listed in The International Who’s Who of Business Lawyers for Life Sciences in 2015, The International Who’s Who of Business Lawyers for Patents in 2013, and The International Who's Who of Patent Lawyers in 2011. She was recognized in 2018 and the nine years immediately preceding as a Georgia "Super Lawyer" in the area of Intellectual Property by Super Lawyers magazine. Ms. Graham has been recognized as one of Georgia Trend's 2012 “Legal Elite” for Intellectual Property Law. She was honored by the Georgia Chapter of the Huntington's Disease Society of America at its 2012 Celebration of Hope Gala. Ms. Graham is a recipient of the prestigious 2015 Georgia Bio Community Award for her significant contributions to Georgia's life sciences industry. Georgia State University and Georgia Institute of Technology honored Ms. Graham in 2017 with the Intellectual Property (IP) Community Service Award for her outstanding contributions to the community. She is AV® rated by Martindale-Hubbell.*
*CV, BV, and AV are registered certification marks of Reed Elsevier Properties Inc., used in accordance with the Martindale-Hubbell certification procedure's standards and policies.
Represents Oklahoma Medical Research Foundation (OMRF) in the preparation and prosecution of patent applications involving anthrax vaccines, magnetic resonance spectroscopy and metabolite detection.
Obtains patents and provides patent counseling for Strategic Diagnostics Inc. ("SDI"). SDI is a leading developer and manufacturer of antibodies, immunoreagents and immunoassay-based test kits for both field testing and laboratory use.
Represented start-up in successfully obtaining U.S. patents for immunodiagnostic assays for early detection and profiling of cancer patients.
Expert witness for global veterinary medicine corporation in litigation involving an animal vaccine.
Represented public health agency in patent prosecution and counseling matters. Prepared and prosecuted patent applications in a variety of biotechnical areas including vaccine and pathogenic organism detection.
Represented a Fortune 500 scientific, engineering, and technology applications company in virus and pathogenic organism micro array detection. The firm worked closely with the company on bioterrorism detection and the Anthrax clean-up in DC.
Represents the National Institutes of Health under government contract and conducts patentability analysis and prosecutes patent applications for government entities such as Centers for Disease Control and Prevention (CDC), and National Cancer Institute (NCI) in biological technologies such as diagnostics, antibodies, vaccines and cancer treatments.
Represents Purafil in preparing and prosecuting to issuance numerous patent applications relating to chemical filtration systems for the removal of contaminants from the environment.
Represents the University of Connecticut under government contract and prosecutes patent applications for biological and chemical technologies such as protein-based photovoltaic energy systems, anti-malarial vaccines, and chemical compounds for the inhibition of yeast growth.
Represent the U.K. Ministry of Defence (MOD), which is responsible for the military and homeland security functions of the United Kingdom, and have prosecuted patent applications for aerospace, defense, biotechnology and chemical technologies. Also represents the technology transfer company affiliated with the MOD whose mission is to commercialize technologies having non-military applications.
Insights View All
Emory University, M.S., Immunology and Molecular Pathogenesis (1995)
Emory University School of Law, J.D. (1985)
Wellesley College, B.A., Molecular Biology (1979)
Not licensed in District of Columbia – practices solely before the USPTO
U.S. Patent and Trademark Office (1986)
Women In BIO - Atlanta Chapter, Immediate Past-President
CDC Foundation, National Advocacy Council
Leadership Atlanta, Class of 2019, Participant
Leadership Council on Legal Diversity (LCLD), 2015 Class of Fellows, Member
Childspring International, Board of Trustees
GA BIO, Board of Directors
Georgia BioEd Institute, Board of Advisors, Immediate Past-Chair
American Chemical Society, member for 30+ years
Atlanta-Based Women In Technology (WIT), Past-President
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.